Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

Aurobindo Pharma’s wholly owned subsidiary Auro Pharma acquires Khandelwal Laboratories’ non-oncology prescription formulations business for Rs 325 crore in a cash slump sale.

Pharmaceuticals are developed, designed, and commonly manufactured in laboratory settings. Laboratory testing is an essential need in almost every stage of pharmaceutical production and R&D, from the ...

Having comprehensive documentation of chemical analyses is crucial for any pharma QC lab. Capturing the entire analytical process – from sample preparation to crucial system components such as sensors ...

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.

The field of drug discovery is inherently complex and plagued by high costs, long development times and high rates of failure. Artificial intelligence (AI) and automation have emerged as ...

Zee Laboratories supplies medicines to government hospitals and institutions such as AIIMS, as well as to central and state ...

Aurobindo Pharma acquires Khandelwal Labs' non-oncology portfolio for ₹325 crore, enhancing its anti-infective and pain ...

The new facilities introduce advanced digital learning environments that integrate virtual reality, immersive simulation, and ...